Somazina

Author:
Actoverco
Date:
16 November 2021
irán nahaleh naraghi big pharma -actoverco

Related Posts

IMGM0506

Visual Report on the Introduction of “gynati” and “prequin”

10 August 2024
actonib launch

Visual Report on the Introduction of Actonib and Its application in Dermatology

31 July 2024
HY6A3173

Neurostyle Launch Event

14 July 2024
nahaleh naraghi

Interview with Nahaleh Naraqi about Actoverco social responsibilities

5 June 2024
the Capital Corona Disease Management Operation1

Dr. Zali, Commander of the Capital Corona Disease Management Operation, visited the Actover Group

8 February 2022